Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoko Matsui

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|May 10, 2005
Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathwayChie Shinoda, Muneharu Maruyama, Takashi Fujishita, et al.
Biochemical and Biophysical Research Communications|October 10, 2006
Isoproterenol suppresses cytokine-induced RANTES secretion in human lung epithelial cells through the inhibition of c-jun N-terminal kinase pathwayKoutarou Miyabayashi, Muneharu Maruyama, Toru Yamada, et al.
Oncology Reports|April 4, 2012
SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in miceKensuke Suzuki, Ryuji Hayashi, Tomomi Ichikawa, et al.
In Vivo (Athens, Greece)|April 29, 2021
Case Series of Pleomorphic Carcinoma of the Lung Treated With Immune Checkpoint InhibitorsKana Hayashi, Kotaro Tokui, Minehiko Inomata, et al.
Kidney International Reports|February 5, 2024
Improved Renal Function in Initial Treatment Improves Patient Survival, Renal Outcomes, and Glucocorticoid-Related Complications in IgG4-Related Kidney Disease in JapanIchiro Mizushima, Takako Saeki, Daisuke Kobayashi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 31, 2014
Relationship of the urine cortisol level with the performance status of patients with lung cancer: a retrospective studyKensuke Suzuki, Tomomi Ichikawa, Hideaki Furuse, et al.
Anticancer Research|February 29, 2024
Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet ChemotherapyMinehiko Inomata, Shuhei Minatoyama, Naoki Takata, et al.
Molecular and Clinical Oncology|April 10, 2023
Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumor‑infiltrating CD68‑positive cell counts in patients with EGFR‑mutant non‑small cell lung cancerTakeshi Tsuda, Kensuke Suzuki, Minehiko Inomata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2017
[A Retrospective Study Analyzing the Clinical Course of Patients with Non-Small Cell Lung Cancer Receiving Local or Systemic Therapy after Post-Operative Recurrence]Minehiko Inomata, Hiroaki Tanaka, Kazuki Shimokawa, et al.
Respirology (Carlton, Vic.)|October 16, 2012
Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthmaTomomi Ichikawa, Ryuji Hayashi, Kensuke Suzuki, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|May 10, 2005
Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathwayChie Shinoda, Muneharu Maruyama, Takashi Fujishita, et al.
Biochemical and Biophysical Research Communications|October 10, 2006
Isoproterenol suppresses cytokine-induced RANTES secretion in human lung epithelial cells through the inhibition of c-jun N-terminal kinase pathwayKoutarou Miyabayashi, Muneharu Maruyama, Toru Yamada, et al.
Oncology Reports|April 4, 2012
SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in miceKensuke Suzuki, Ryuji Hayashi, Tomomi Ichikawa, et al.
In Vivo (Athens, Greece)|April 29, 2021
Case Series of Pleomorphic Carcinoma of the Lung Treated With Immune Checkpoint InhibitorsKana Hayashi, Kotaro Tokui, Minehiko Inomata, et al.
Kidney International Reports|February 5, 2024
Improved Renal Function in Initial Treatment Improves Patient Survival, Renal Outcomes, and Glucocorticoid-Related Complications in IgG4-Related Kidney Disease in JapanIchiro Mizushima, Takako Saeki, Daisuke Kobayashi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 31, 2014
Relationship of the urine cortisol level with the performance status of patients with lung cancer: a retrospective studyKensuke Suzuki, Tomomi Ichikawa, Hideaki Furuse, et al.
Anticancer Research|February 29, 2024
Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet ChemotherapyMinehiko Inomata, Shuhei Minatoyama, Naoki Takata, et al.
Molecular and Clinical Oncology|April 10, 2023
Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumor‑infiltrating CD68‑positive cell counts in patients with EGFR‑mutant non‑small cell lung cancerTakeshi Tsuda, Kensuke Suzuki, Minehiko Inomata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2017
[A Retrospective Study Analyzing the Clinical Course of Patients with Non-Small Cell Lung Cancer Receiving Local or Systemic Therapy after Post-Operative Recurrence]Minehiko Inomata, Hiroaki Tanaka, Kazuki Shimokawa, et al.
Respirology (Carlton, Vic.)|October 16, 2012
Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthmaTomomi Ichikawa, Ryuji Hayashi, Kensuke Suzuki, et al.
Pageof 9